In addition to traditional ketamine treatments given by injection, orally, or infusion, there’s a different form of ketamine treatment called esketamine (brand name Spravato) which may be inhaled nasally.
Esketamine therapy is administered under direct medical supervision and has been FDA-approved in the U.S. for treatment-resistant depression. Spravato therapy is typically prescribed alongside other antidepressants.
The primary benefit of Spravato (esketamine) is its rapid effectiveness, making it a preferred option for psyschedelic therapy treatment. For individuals combatting treatment-resistant depression or thoughts of suicide, its quick response time is a major benefit to this form of treatment.
Esketamine reaches peak concentrations within 20 to 40 minutes, working much faster than traditional antidepressants. It is often recommended for acute major depressive episodes or self-harm ideation.
Your practitioner will determine your appropriate dose, which involves administering nasal puffs from one or more dispensers.
A 56 mg dose requires two devices, while an 84 mg dose uses three. Each puff is taken under supervision, followed by a five-minute rest to ensure absorption.
Esketamine can cause sedation, so patients must remain in our Westchester, NY clinic for at least two hours post-treatment until cleared to leave. A ride home with assistance is required.
Treatment typically starts with twice-weekly doses for the first month. After this period, an evaluation will determine whether adjustments to esketamine therapy are necessary.
Your provider may modify your Spravato therapy based on your response.
excess sedation (tired feeling) after treatment, so it’s generally required that patients remain in the clinic for at least 2 hours until it’s determined that it’s safe for them to leave. You’ll need to have someone help you get home.
There is a risk for abuse and dependence with prolonged esketamine (Spravato) therapy treatment. Your health care provider will evaluate your history and condition to establish whether esketamine is an appropriate option for you.
SPRAVATO has been FDA-approved for certain conditions, so there’s an excellent chance that if you qualify as a candidate, your insurance will cover Spravato.
All policies are different, though, so be sure you discuss your coverage with your provider. Our clinic in Westchester County, NY can help you to determine whether your coverage will extend to treatment with Spravato.
PMC Psychedelic is a leading provider of innovative and effective treatments for mental health conditions. Our clinic in New York offers a range of cutting-edge therapies, including ketamine infusion therapy, TMS, and med management. We also offer telehealth services for patients who cannot travel to our clinic. Our experienced team is dedicated to helping you overcome your mental health challenges and regain your quality of life.
© Copyright 2023 Psychedelic Medicine Centers of America
